NovaQuest Capital Management is a leading investor in life sciences and healthcare through our BioPharma and Private Equity strategies.


NovaQuest was formed in 2000 with the vision of building an investment platform to provide strategic capital to life sciences and healthcare companies. Today, NovaQuest Capital Management manages over $1.6 billion through two platforms: BioPharma and Private Equity.

Our team of investment professionals have significant investment experience and deep life science and healthcare expertise. Furthermore, NovaQuest benefits from a large network of industry experts that look to help identify and potentially assist NovaQuest portfolio companies and investments.



NovaQuest BioPharma manages product and company-related investments in the global healthcare industry. Our primary focus is product-based investments in late-stage clinical and commercial BioPharma programs. The BioPharma team has worked together since 2000 and brings over 100 years of collective deal-making experience. Our strategy and investments are customized to meet the structural, accounting, and governance needs of our partners and to provide material co-funding to the industry.

Private equity

NovaQuest Private Equity is focused on partnering with management teams to build leading healthcare companies in the middle market. We look to transform market leaders into larger, better-positioned, more valuable enterprises. In many cases, we will utilize our strategic partners, Operating Advisory Board, and deep industry network to benefit our investments. Healthcare is a large and exciting sector, but it’s crucial to have the right partners to better navigate the growth curve.